Arrhythmia burden and related outcomes in Eisenmenger syndrome

Congenital Heart Disease
Shankar BaskarGruschen Veldtman

Abstract

Patients with Eisenmenger syndrome have a shorter lifespan than the general population. A significant proportion develop arrhythmia and some, sudden death. The aims of this study were to characterize the frequency, type and effects of arrhythmias in adult patients with Eisenmenger's syndrome and to identify risk factors for arrhythmias. This retrospective study included patients aged ≥ 18 years of age with Eisenmenger's syndrome from three institutions. Arrhythmias were noted from electrocardiograms and Holter study reviews. A total of 167 patients, 96 females, 63 males (gender not available in 9 patients) were included in this study. The mean age was 38 ± 9 years (range: 18-63 years) with a majority in NYHA functional class II or III (57% and 32% respectively). Twenty-eight patients (17%) had significant tachyarrhythmia: paroxysmal supraventricular tachycardia (8 patients, 29%), atrial fibrillation (6 patients, 21%), atrial fibrillation and flutter (2 patients, 7%), nonsustained ventricular tachycardia (6 patients, 21%) and sustained ventricular tachycardia (6 patients, 21%). Among the entire study group, 26 patients (16%) were currently on antiarrhythmic therapy and 77 patients (49%) were on advanced therapies for pulmonary h...Continue Reading

References

Jan 1, 1971·The British Journal of Surgery·R B WelbournT L Kennedy
Jan 14, 1999·European Heart Journal·L DalientoS Stone
Sep 25, 1999·The American Journal of Cardiology·W J CantorS C Siu
Nov 25, 2000·Journal of the American College of Cardiology·M Malik, V N Batchvarov
Jan 31, 2007·Circulation·Edward P Walsh, Frank Cecchin
Apr 1, 2008·Journal of Cardiovascular Electrophysiology·Tomoko SakaguchiMinoru Horie
Sep 1, 2011·Expert Review of Cardiovascular Therapy·Ali A Sovari, Hrayr S Karagueuzian
Sep 20, 2012·Circulation·Zeliha KoyakBarbara J M Mulder
Jun 3, 2014·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Craig S BrobergMichael A Gatzoulis
Oct 1, 2015·PloS One·Christopher G SobeyVelandai K Srikanth
Feb 5, 2016·European Heart Journal·Gerhard-Paul DillerUNKNOWN German Competence Network for Congenital Heart Defects Investigators
Jun 25, 2016·Nature Reviews. Drug Discovery·Robert G GourdiePeter Kohl

❮ Previous
Next ❯

Citations

Jul 22, 2020·Heart·Alexandra ArvanitakiAstrid Elisabeth Lammers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.